Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Screening for sleep disorders in internal medicine as potential comorbidities of systemic autoimmune diseases and improving patients' quality of life].

La Revue de medecine interne·2024

Same author

Nocturnal agitation: From sleep state dissociation to sleep-related dissociative state.

Revue neurologique·2023

Same author

Evaluation of hypersomnolence: From symptoms to diagnosis, a multidimensional approach.

Revue neurologique·2023

Same author

Environmental psychiatry: A proposed framework to address the global mental health burden.

L'Encephale·2022

Same author

Screening and treatment of Post-Selective Serotonin Reuptake Inhibitors sexual dysfunctions.

L'Encephale·2022

Same author

The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohort.

European archives of psychiatry and clinical neuroscience·2022

Search research articles

Related Experiment Video

Updated: May 10, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

[Interactive rTMS protocols in psychiatry].

J-A Micoulaud-Franchi¹, R Richieri, C Lancon

¹Solaris, pôle de psychiatrie universitaire, CHU Sainte-Marguerite, 270, boulevard Sainte-Marguerite, 13009 Marseille, France; INCM-CNRS UMR 6193, institut de neurosciences cognitives de la Méditerranée, 31, chemin Joseph-Aiguier, 13402 Marseille cedex 20, France; Université d'Aix-Marseille, 58, boulevard Charles-Livon, 13284 Marseille cedex 07, France; Unité de neurophysiologie, psychophysiologie et neurophénoménologie, pôle de psychiatrie universitaire, CHU Sainte-Marguerite, 270, boulevard Sainte-Marguerite, 13009 Marseille, France.

|July 2, 2013

Summary

Interactive repetitive transcranial magnetic stimulation (rTMS) enhances psychiatric treatments by engaging cognitive and brain activities during stimulation. This approach optimizes neural circuit responses for conditions like major depressive episode and schizophrenia.

Keywords:

Adaptation Alpha EEG Cognitive Major depressive disorder Stimulation magnétique transcrânienne Transcranial magnetic stimulation Épisode dépressif majeur

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Related Experiment Videos

Last Updated: May 10, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

Area of Science:

Neuroscience
Psychiatry
Neuromodulation

Background:

Repetitive transcranial magnetic stimulation (rTMS) shows efficacy for major depressive episode (MDE) and schizophrenia but requires protocol optimization.
The concept of "state dependency TMS" highlights that neural circuit activation states influence stimulation effects.
Interactive rTMS protocols aim to increase treatment efficiency by engaging patients' neurocognitive activities during stimulation.

Purpose of the Study:

To review and classify interactive rTMS protocols for treating MDE and schizophrenia.
To discuss how these protocols interact with cognitive and brain electrical activities.

Main Methods:

Review of interactive rTMS protocols manipulating cognitive activities (e.g., emotional tasks, CBT rTMS, affective rTMS) for MDE.
Classification of interactive rTMS protocols manipulating brain electrical activities for MDE and schizophrenia.
Identification of personalized rTMS (online contingent rTMS, offline alpha rTMS) and brain activity modulation techniques (tDCS rTMS, EEG-biofeedback rTMS).

Main Results:

Interactive protocols for MDE involve emotional tasks to enhance left dorsolateral prefrontal cortex (DLPFC) sensitivity to rTMS.
Personalized rTMS protocols tailor stimulation parameters (e.g., frequency) based on individual brain activity (EEG).
Brain activity modulation techniques like tDCS rTMS and EEG-biofeedback rTMS aim to optimize DLPFC stimulation conditions.

Conclusions:

Interactive rTMS protocols represent a novel approach in psychiatric treatment, integrating cognitive and cerebral activities.
Current studies are often exploratory with small sample sizes, and the neurocognitive framework requires further clarification.
This innovative therapeutic avenue holds promise for advancing psychiatric interventions by considering neural activity as integral to treatment.